Vivos Therapeutics, Inc.
VVOS
Rank in Stocks
#32663
Vivos Therapeutics, Inc. operates as a medical technology company that develops... Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Share Price
$0.0958
Last synced: 2026-11-09
Market Cap
$1.33M
Change (1 day)
2.24%
Change (1 year)
-96.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vivos Therapeutics, Inc. (VVOS)
Category
Healthcare
Operating Margin for Vivos Therapeutics, Inc. (VVOS)
Operating Margin as of November 2026 TTM: -107.92%
According to Vivos Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is -107.92%. At the end of 2025 the company had an operating margin of -114.05%.
Operating Margin history for Vivos Therapeutics, Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -107.92% | -5.37% |
| 2025 | -114.05% | 53.46% |
| 2024 | -74.32% | -40.70% |
| 2023 | -125.32% | -19.77% |
| 2022 | -156.21% | 35.46% |
| 2021 | -115.32% | 73.02% |
| 2020 | -66.65% | -28.21% |
| 2019 | -92.84% | -57.77% |
| 2018 | -219.82% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.14% |
US
|
|
| 18.08% | -100.17% |
IE
|
|
| 21.25% | -100.20% |
US
|
|
| 21.05% | -100.20% |
US
|
|
| 28.09% | -100.26% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Vivos Therapeutics, Inc.'s operating margin
What is Vivos Therapeutics, Inc.'s operating margin?
Vivos Therapeutics, Inc.'s operating margin is -107.92%, as of Nov 2026.
What was Vivos Therapeutics, Inc.'s operating margin in 2025?
In 2025, Vivos Therapeutics, Inc.'s operating margin was -114.05%, compared with -74.32% in 2024.
How has Vivos Therapeutics, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Vivos Therapeutics, Inc.'s operating margin was highest in 2020 (-66.65%) and lowest in 2022 (-156.21%).
How does Vivos Therapeutics, Inc.'s operating margin compare with similar companies?
Vivos Therapeutics, Inc.'s operating margin (-107.92%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.